Biotechnology
ETANA HAS SECURED B ROUND FINANCING
JAKARTA, Indonesia, Sept. 28, 2022 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured B round of financing led by Yunfeng Capital and followed by HighLight Capital. This round of financing will be mainly used for further strengthening ...
2022-09-28 09:00
4102
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate
MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved a pivotal Phase III registration study that will bridge ...
2022-09-28 06:50
1344
CP KELCO PARTNERS WITH EXOPOLYMER TO BRING NEXT-GENERATION FUNCTIONAL BIOPOLYMERS TO MARKET
ATLANTA, Sept. 27, 2022 /PRNewswire/ -- CP Kelco, a global leader of nature-based ingredient solutions that is owned by J.M. Huber Corporation, and ExoPolymer, Inc., a biotechnology startup company focused on developing new-to-the-world, polysaccharide-based biopolymers, are excited to announce a ...
2022-09-27 21:00
1297
Metabolon Expands Data Access Strategy to Include Health for Life in Singapore (HELIOS) Study
Metabolon to collaborate with NTU Singapore's medical school to identify biomarkers for the prevention, diagnosis, and treatment of disease. MORRISVILLE, N.C., Sept. 27, 2022 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of res...
2022-09-27 19:57
1481
Sciwind Biosciences and SynerK Enter into Research Partnership to Discover and Develop Novel siRNA Therapeutics
The partnership combines Sciwind's expertise in disease biology and clinical development capabilities with SynerK's proprietary conjugate-based siRNA delivery technology and expertise in developing RNAi therapeutics SAN FRANCISCO, Calif. and HANGZHOU, China, Sept. 27, 2022 /PRNewswire/ -- Sciwin...
2022-09-27 08:00
1897
First Patient Enrolled in ProstACT TARGET Study
MELBOURNE, Australia, Sept. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and GenesisCare, the largest provider of integrated cancer care inAustralia, today announce that a first patient has been enrolled in the Phase II ProstACT TARGET study of Telix's pro...
2022-09-27 05:00
1652
Brii Biosciences Announces Top-line Results from Phase 1 Study of BRII-296, A Long-Acting Therapy in Development for Postpartum Depression
* Data demonstrated that a single administration of BRII-296 at 600 mg delivered a favorable pharmacokinetic profile and is safe and well-tolerated in healthy subjects * Findings suggest BRII-296 has potential to provide a safe and effective, one-time injectable treatment option to people wit...
2022-09-26 20:00
2062
CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world's premier diabetic foot conference (DFCon) in Los Angeles
- CRC data on cord lining media for the treatment of diabetic foot ulcers has been accepted at the DFCon, with DrWong Keng Lin Francis, CRC's latest KOL, presenting his findings to world leaders in the field of DFU. - Similarly, the results of Corlicyte™'s Phase 1 study on the treatment of chro...
2022-09-26 13:44
1407
Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases
Advancement highlights Everest's potential in providing first-in-class
therapies to global patients with glomerular disease
SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- Everest Medicines
2022-09-26 08:00
2270
Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities
SINGAPORE, Sept. 23, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the official opening of its office and research facilities at the Singapore Sc...
2022-09-23 17:00
1693
WINNERS OF THE 2023 BREAKTHROUGH PRIZES IN LIFE SCIENCES, MATHEMATICS AND FUNDAMENTAL PHYSICS ANNOUNCED
$15.75 Million in Prizes Awarded for Predicting Protein Structure with Deep Learning, Pioneering Field of Quantum Information, and Discoveries with Applications from Treating Neurodegenerative Disease to Optimizing Video Transmission Breakthrough Prize in Life Sciences Awarded to Clifford P. Bra...
2022-09-22 21:25
1906
Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
-- CK0803 are neurotropic, allogeneic, umbilical cord blood derived T regulatory (Treg) cells -- CK0803 represents the company's fifth program to receive IND Clearance utilizing Cellenkos' proprietaryCRANE™ technology HOUSTON, Sept. 22, 2022 /PRNewswire/ -- Cellenkos, Inc., a clinical stage bio...
2022-09-22 13:59
1216
Far Eastern New Century won the "Sustainability & Innovation Award" from ITMF Awards 2022 with FENC® TOPGREEN® Bio3
FENC® TOPGREEN® Bio3, World No.1 Fabric made from waste gas reuse technology & N66 solution dye. TAIPEI, Sept. 21, 2022 /PRNewswire/ -- As the pioneer in innovation and sustainability, Far Eastern New Century Corporation (FENC) is able to provide solutions to lower the environmental impact for b...
2022-09-21 20:00
1666
HIKE Capital rides green wave to seize future
BEIJING and SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- As the world is undergoing an energy restructuring, HIKE Capital, a leading founders' fund in China, has been committed to seizing the opportunities that emerged in the new era, which has been shaped by carbon reduction and digital technology. ...
2022-09-21 13:53
1682
Excelra partners with Patcore, Inc.
The partnership expands Excelra's scientific products footprint in the Japanese market HYDERABAD, India and TOKYO, Sept. 21, 2022 /PRNewswire/ -- Excelra today announced a partnership with Patcore, Inc., providing greater access to Excelra's scientific data and analytics products for customers i...
2022-09-21 12:30
2802
SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore
SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd (SCG), has announced today the establishment of a state-of-the-art cell therapy research and manufacturing hub inSingapore. With the support of the Singapore Economic Development Board (EDB), the hub comprises a pi...
2022-09-21 11:00
2679
Final IPAX-1 Study Data Confirms Safety and Tolerability Profile for TLX101, Preliminary Efficacy Data
MELBOURNE, Australia, Sept. 21, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports the final results from the IPAX-1 Ph I/II study of TLX101 therapy (4-L-[131I] iodo-phenylalanine, or 131 I-IPA) in combination with external beam radiation therapy (EBRT)...
2022-09-21 07:51
1186
Glyscend Therapeutics Releases New Phase 1 Biomarker Results and Initiates Phase 2 Clinical Trial under an IND for GLY-200 as a Potential First-in-Class Type 2 Diabetes Treatment
GLY-200 is a First-in-Class, Oral, Gut-Targeted Approach for Treatment of Type 2 Diabetes and Related Metabolic Conditions Newly Released Phase 1 Biomarker Data is Consistent with Effects of Roux-en-Y Gastric Bypass Surgery and Duodenal Exclusion Devices Initial Data from Phase 2 Trial Evaluatin...
2022-09-21 05:33
1219
Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections
* Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections inChina * The deal brings together Melinta's innovation, Menarini's cross-regional expertise in registration and market...
2022-09-20 17:00
2039
Jialian Biotech Group To Participate At Vitafoods Asia 2022 In Bangkok
TAIPEI, Sept. 20, 2022 /PRNewswire/ -- Leading Taiwanese health-care supplements manufacturer Jialian Biotech Group (Jialian) is excited to announce its participation in Vitafoods Asia 2022 –Asia's leading nutraceutical event – inBangkok from October 5th to October 7th, 2022. Headquartered in T...
2022-09-20 14:01
1778
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 309 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 280 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2965
Ferretti's Dazzling Presence at the 2024 Singapore Yachting Festival: Showcasing Evolving Trends in Luxury Yachting
2024-04-28 15:02
2963
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
2024-04-28 09:39
2847